Scipio Bioscience

company

About

A Paris-based biotechnology company .

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
€6M
Industries
Biopharma,Biotechnology,Clinical Trials
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

Scipio Bioscience, a Paris-based biotechnology company, provides a novel sample preparation solutionfor single-cell studies, in the form of benchtop kits, for use in sequencing applications in clinical and basic research, in particular transcriptomics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€6M
Scipio Bioscience has raised a total of €6M in funding over 2 rounds. Their latest funding was raised on Feb 25, 2020 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 25, 2020 Series A €6M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Scipio Bioscience is funded by 1 investors. Verve Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Verve Ventures Series A